Tria Gen Wealth Management LLC Gilead Sciences, Inc. Transaction History

Tria Gen Wealth Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 02, 2021	SELL	$63.47 - $69.35 $1.16 Million - $1.27 Million	-18,300 Closed	0 $0
Q1 2021 Apr 26, 2021	SELL	$60.0 - $68.46 $12,000 - $13,691	-200 Reduced 1.08%	18,300 $1.18 Million
Q4 2020 Feb 02, 2021	BUY	$56.65 - $64.55 $1.05 Million - $1.19 Million	18,500 New	18,500 $1.08 Million

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Tria Gen Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tria Gen Wealth Management LLC with notifications on news.